Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gastroesophageal Cancer × relatlimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 9 Stomach Neoplasms 2 Recurrence 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uveal Melanoma 1 Turcot syndrome 1 Tertiary Lymphoid Structures 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Sarcoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Microsatellite Instability 1 Locally Advanced Melanoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Gastroesophageal Cancer 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Chordoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Carcinoma 1 Brain Neoplasms 1

Interventions

relatlimab 1 Ramucirumab 1 Nivolumab 1 Drug Therapy 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610711 2025-12-22

REACTION

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting

Gastrointestinal

Gastroesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡